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Hereditary Hemorrhagic TelangiectasiaVascular patterning depends on precisely coordinated timing of endothelial cell differentiation and onset of
cardiac function. Endoglin is a transmembrane receptor for members of the TGF-β superfamily that is
expressed on endothelial cells from early embryonic gestation to adult life. Heterozygous loss of function
mutations in human ENDOGLIN cause Hereditary Hemorrhagic Telangiectasia Type 1, a vascular disorder
characterized by arteriovenous malformations that lead to hemorrhage and stroke. Endoglin null mice die
in embryogenesis with numerous lesions in the cardiovascular tree including incomplete yolk sac vessel
branching and remodeling, vessel dilation, hemorrhage and abnormal cardiac morphogenesis. Since defects
in multiple cardiovascular tissues confound interpretations of these observations, we performed in vivo
chimeric rescue analysis using Endoglin null embryonic stem cells. We demonstrate that Endoglin is
required cell autonomously for endocardial to mesenchymal transition during formation of the endocardial
cushions. Endoglin null cells contribute widely to endothelium in chimeric embryos rescued from cardiac
development defects, indicating that Endoglin is dispensable for angiogenesis and vascular remodeling in
the midgestation embryo, but is required for early patterning of the heart.
© 2009 Elsevier Inc. All rights reserved.Introduction
Development of the mammalian embryonic vasculature begins
during gastrulation with the emergence of VEGFR2 (Flk-1)
expressing mesodermal progenitors that give rise to hemato-
poietic and endothelial cells (ECs), as well as cardiac myocyte
and mural cell progenitors (Huber et al., 2004; Kattman et al.,
2007). In addition, formation of the vascular network is tightly
coupled to the differentiation and morphogenesis of the heart to
achieve unidirectional blood ﬂow. Recent studies have highlighted
the dependence of angiogenesis on hemodynamic ﬂow in avian
(le Noble et al., 2004) and mouse embryos (Lucitti et al., 2007),
indicating that vascular patterning depends critically on the
coordinated timing of endothelial/hematopoietic cell differentiation
and onset of cardiac function.
Endoglin is a transmembrane accessory receptor for several
members of the TGF-β superfamily including TGFβ1, TGFβ3, activin,
BMP2, BMP7 and BMP9 (Barbara et al., 1999; David et al., 2007). It iss Centre S-234, 2075 Bayview
16 480 5703.
).
ll rights reserved.expressed in the progenitors to cardiovascular lineages in the
embryo, becoming restricted to ECs from early gestation to adult
life (Allinson et al., 2007; Bourdeau et al., 2000; Ema et al., 2006;
Hirashima et al., 2004). The critical role of Endoglin in the vascular
system is highlighted by the identiﬁcation of human ENDOGLIN
(ENG) as the gene mutated in Hereditary Hemorrhagic Telangiectasia
type 1 (HHT1). Heterozygosity for mutant alleles of Endoglin is
associated with arteriovenous malformations (AVMs) that can lead to
stroke and severe internal hemorrhage(Abdalla and Letarte, 2006;
Bourdeau et al., 2001). Due to the clinical importance of HHT, previous
investigations of Endoglin function have concentrated on its role in
blood vessel endothelium, where it regulates proliferation, migration,
and capillary tube formation (Jerkic et al., 2006) and also modulates
vascular tone in response to hemodynamic stress (Jerkic et al., 2004;
Toporsian et al., 2005).
The essential role of Endoglin in cardiovascular development
was previously documented (Arthur et al., 2000; Bourdeau et al.,
1999; Carvalho et al., 2004; Li et al., 1999; Sorensen et al., 2003).
Mice homozygous for a null allele of Endoglin (Eng) mice do not
survive embryogenesis and succumb to circulatory arrest and
hemorrhage by embryonic day (E)10.5 of gestation. These embryos
display numerous lesions in the cardiovascular tree, including a
vasculature lacking integrity, with perturbed mural cell association
and/or differentiation as well as improper segregation of arterial
Table 1
Summary of chimera analysis.
Aggregation
no.
Total Eng+/−
Chimeric Embryos
Total Eng−/− Chimeric Embryos
Type 1 Type 2 Type 3
1 8 11 1 5
2 24 14 2 3
3 14 20 4 37
Total 46 45 7 45
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addition, the yolk sac vasculature showed incomplete vessel
branching, severe dilation and hemorrhage.
Importantly, Endoglin-deﬁcient embryo hearts do not undergo
normal morphogenetic looping, and display reduced trabeculation
of the ventricles, and pericardial edema indicative of circulatory
arrest. These defects coincide with abrogated endocardial cushion
formation in the atrioventricular canal (AVC) (Bourdeau et al.,
1999). In this process, reciprocal signaling between the endocar-
dial and myocardial cell layers within the AVC induces transfor-
mation of endocardial cells into mesenchymal cells that migrate
and invade the localized swelling of the extracellular matrix
(Armstrong and Bischoff, 2004). The atrioventricular (AV) mesen-
chyme subsequently differentiates into the ﬁbrous tissues of the
valves (Person et al., 2005). In support of a role in heart
morphogenesis, Endoglin is expressed in endocardium and AVC
mesenchyme during development (Arthur et al., 2000; Bourdeau
et al., 1999; Ema et al., 2006).
Analysis of Eng-null embryos was instrumental in determining
the overall importance of this receptor during development and in
the identiﬁcation of the developmental stage and cell types
primarily affected by the mutation. However, embryonic lethality
with complex abnormalities in interdependent cell lineages has
hindered determination of the speciﬁc stage at which this receptor
plays a role in patterning the cardiovascular tree. To address this
problem we used Eng-deﬁcient and control embryonic stem (ES)
cells in vivo in chimeric mice to investigate the developmental
potential and cellular characteristics of Eng-deﬁcient cardiovascular
lineage cell types. Our studies have uncovered a cell autonomous
requirement for Endoglin in the formation of endocardial cushions
by endocardial to mesenchymal transition (EMT), and patterning of
the myocardium of the AVC. We also show that Endoglin is not
required cell-autonomously for angiogenesis in the midgestation
embryo, and that vessel defects in the absence of Endoglin are
attributed to abnormal cardiac morphogenesis.
Materials and methods
Derivation of ES cells
Eng+/− ES cells were previously generated (Bourdeau et al.,
1999) by gene targeting the parental wild-type 129/Ola-derived
E14 ES cell line, replacing 609 base pairs (bp), including exon 1 of
Eng and its initiation codon, with the Escherichia coli LacZ gene.
Eng−/− ES cells were generated from one Eng+/− clone by
selection with high concentration G418 (5.0 mg/mL) for 10 days
(Nagy et al., 2003). PCR was used to screen resistant colonies for
wild-type and targeted alleles (Bourdeau et al., 1999) (Supple-
mentary Fig. 1). Two independently derived Eng−/− clones and
two independent Eng+/− clones (unrecombined after identical
selection) were used for ES cell differentiation experiments and
chimera aggregations.
Aggregations and chimeric embryo analysis
Chimeric mice were produced by aggregation of wild-type host
embryos (8-cell morulae) with Eng+/− and Eng−/− ES cells (embryo
← → ES cell aggregation) as previously described (Wood et al.,
1993). All chimeric embryos were stained for X-gal as previously
described (Puri and Bernstein, 2003) to detect donor derived β-
galactosidase expressing cells. Embryos were ﬁxed and embedded in
parafﬁn, sectioned and counterstained with Nuclear Fast Red. Extent
of chimerism for all individual chimeras was determined using
quantitative genomic PCR (Table 1) and glucose phosphate isome-
rase (GPI) as previously described (Puri and Bernstein, 2003)
(Supplementary Fig. 2).Determination of donor-derived ES cell contribution to chimeric mice by
real-time quantitative genomic PCR
PCR primers amplify a region of the Eng mutant allele (donor
cells) and the Tie2 allele for baseline genome (all cells). The con-
tribution of donor cells was quantiﬁed relative to this. Chimera
embryo yolk sacs were digested in PCR lysis buffer and proteinase K
overnight at 55 °C. 100 ng of nucleic acid, quantiﬁed by Nanodrop
(Thermo Scientiﬁc) was used for quantitative real-time PCR for each
sample. The amount of donor cell DNA was determined by
comparing the amount of Endoglin-LacZ amplicons in each sample
to a standard curve created from a dilution series of pooled DNA
from digested yolk sacs of Eng−/− embryos. The amount of host cell
DNA was determined by comparing the amount of Tie2 amplicons in
each sample to a standard curve created from the same dilution
series of pooled Eng−/− DNA. The number of Eng-LacZ amplicons
relative to the number of Tie2 amplicons in each sample determined
the percent donor cell contribution. The primer sequences were as
follows: LacZF (5′TATCTCTGGATACCGGATAAG3′); LacZR (5′TGTAAA-
ACGACGGGATCATCG3′); Tie2F (5′AAGAGCGAGTGGACCATGCGA3′),
Tie2R (5′AGGAGCAAGCTGACTCCACAG3′).
Quantitative chimera contribution data are summarized in
Table 1 and shown in detail in Supplementary Table 1.
Embryoid body formation and in vitro angiogenesis assay
ES cells were cultured on irradiated murine embryonic ﬁbro-
blasts (MEFs) in ES cell medium and 2000 U/mL recombinant leu-
kemia inhibitory factor (LIF; Chemicon International). Differentiation
of ES cells was induced by withdrawal of LIF and by aggregating the
cells into embryoid bodies (EBs) by culturing 1200 cells/drop on the
lid of a non-adherent 96-well tissue culture dish for 4 days.
Individual EBs were plated into one well of an eight-well glass
culture slide (Becton Dickinson (BD) Falcon) for 6 days. Flattened
EBs were stained with a monoclonal rat anti-mouse PECAM-1
antibody (CD31, BD Pharmingen), overnight at 4 °C, followed by
incubation with biotinylated goat anti-rat IgG (Vector Laboratories).
Atrioventricular cushion explant culture
Timed matings between Eng+/− mice were established with the
morning of a vaginal plug deﬁned as E0.5. All embryos used were
21–25 somites. AVC explant cultures were established as described
previously (Camenisch et al., 2002). The AVC and adjacent
myocardium from the embryos were dissected and explanted onto
type I collagen (Sigma-Aldrich) and allowed to attach for 12 h.
Explant cultures were scored for mesenchymal cell invasion at 24
and 48 h and photographed using an inverted Leica DM IL
microscope. Migrated mesenchymal cells were identiﬁed and
counted below the gel surface (Runyan and Markwald, 1983) before
the genotype of the respective embryo was determined.
Quantitative real-time gene expression analysis
Heart tissue from E9.5 embryos collected from Eng+/−
heterozygote intercrosses were pooled according to genotype
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(Invitrogen) and cDNAs were generated using the Superscript III
Reverse Transcriptase kit (Invitrogen). The quantity of cDNA in each
sample was quantiﬁed using Nanodrop (Thermo Scientiﬁc). Real-
time PCR was performed on an ABI Prism 7000 (Applied Biosystems)
with primers listed in Supplementary Table 2 and normalized to β-
actin. Each qPCR was performed in triplicate, and each test was
performed at least ﬁve times with pools of embryonic tissue from
separate littermate collections. A two-tailed Student's t-test (for
parametric data with equal variances) was used for statistical
analysis.
Whole mount RNA in situ hybridization
Analysis of gene expression in whole embryos was performed as
previously reported (Saga et al., 1996). In brief, digoxigenin (DIG)-
labelled RNA probe was used to detect mRNA, and probe/mRNA
hybrid was detected by alkaline-phosphatase (AP)-labelled anti-DIG
antibody (Roche) with BCIP/NBT chromogen (DAKO). Three to six
somite-number matched mutant and wild-type embryos were used
for each probe.
Proliferation and apoptosis analysis
Proliferating and apoptotic cells were detected with anti-
phosphohistone H3 (PHH3) antibody (Cell Signalling, 1:100 dilution)
and in situ cell death detection kit, TMR red (Roche), respectively.
Alexa 488 conjugated anti-rabbit antibody (Invitrogen/Molecular
Probes, 1:250 dilution) and Topro3 (Invitrogen, 1:1000 dilution)
were used to detect PHH3 and nuclei, respectively. Embryos were
embedded in parafﬁn, sectioned (7 μm), and imaged on a Zeiss
LSM510 confocal microscope. Three wild-type and three mutant
embryos were sectioned and two or three sections including AVC
were compared from each embryo.
Results
Endoglin-deﬁcient cells contribute to angiogenesis in chimeric embryos
Previous analysis of Eng-deﬁcient embryos demonstrated defects
in angiogenesis both in the yolk sac and in the embryo proper
(Arthur et al., 2000; Bourdeau et al., 1999; Li et al., 1999) suggesting
that Eng-null ECs are compromised in their ability to expand and
mature beyond the early differentiation stage of angiogenesis,
leading to hemorrhage, growth delay and circulatory arrest. To test
whether there is a cell autonomous requirement for Endoglin in
angiogenic sprout formation, we compared the ability of Eng-
deﬁcient vs. control embryonic stem (ES) cells to form EC sprouts
in chimeric embryos.
Generating chimeric (or mosaic) animals composed of mixtures
of wild-type and mutant cells provides one means to analyze genes
that are required in different tissues and at multiple stages of
development. Chimeric mice were produced by aggregation of wild-
type host embryos and either Eng+/− or Eng−/− ES cells, where
the host cells rescue the cellular deﬁciencies conferred by the
mutant donor population, thus allowing the analysis of the beha-
viour of mutant cells in a competitive environment. Since the Eng-
null allele was produced by insertion of LacZ gene into the ﬁrst
translated exon (Bourdeau et al., 1999), mutant and heterozygous
donor cells that normally express Eng are stably labeled with β-
galactosidase, allowing their identiﬁcation in chimeric animals
following X-gal staining.
Eng−/− embryos die by E9.5–10.0, therefore we analyzed Eng-null
and control chimeric embryos at E10.5–11.5, to follow the fate of
mutant vs. control cells in embryos that had been rescued of the
deleterious effects of Eng loss of function (Table 1; Fig. 1). In additionto X-gal staining, we determined the extent of chimerism using a
quantitative PCR assay to determine the relative presence of the
mutant allele (Supplementary Table 1), or glucose phosphate iso-
merase (GPI) Assay to distinguish donor vs. host cells carrying GPI-AA
vs. GPI-BB isoforms, respectively (Supplementary Fig. 2). Previous
studies (Bourdeau et al., 1999) and Supplementary Fig. 3 indicate that
LacZ is expressed equally robustly in Eng+/− and Eng−/− embryos,
validating that β-galactosidase marks cells in which the Endoglin
promoter is active and that the reporter gene expression is not
affected by loss of Endoglin function.
E10.5 chimeric embryos derived from Eng+/− donor cells were all
developmentally normal and displayed a range of donor cell contri-
bution (n=46) (Figs. 1A, E, I). In contrast, E10.5 embryos derived
from aggregation with Eng−/− cells displayed one of three distinct
patterns: (Type 1) mosaicism of b20% donor cells (Figs. 1B, F, J)
(n=45); (Type 2) mosaicism of 20–50% donor cells (Figs. 1C, G, K)
(n=7) and (Type 3) mosaicism of N50% donor cells (Figs. 1D, H, L)
(n=45). Although Type 1 and Type 2 embryos were developmentally
normal, all Type 3 embryos recapitulated the Eng-null phenotype,
displaying growth delay, incomplete vessel development, and
pericardial edema (Figs. 1D, H, L). Types 1 and 2 embryos show that
Eng−/− cells have the ability to contribute to angiogenic sprouting in
many tissues.
Comparison of X-gal staining between Eng+/− and Eng−/−
Type 2 (rescued) chimeras demonstrated that Eng-null cells
contribute to both intersomitic sprouts from the dorsal aorta, and
branching vessels from the cardinal vein in the cranial region
(Figs. 1C, G, K). Furthermore, Eng−/− ECs can migrate and sprout
into the neural ectodermal tissue of the developing brain to an
equivalent extent as heterozygous donor cells. (Figs. 2A, B). Also,
sections of X-gal-stained yolk sac tissue from mutant and hetero-
zygous chimeric embryos demonstrate that Eng-null cells also
contributed to the endothelium of the yolk sac blood islands
(Figs. 2C, D). All Type 1 and Type 2 wild-type← → Eng−/−
chimeras such as those shown in Figs. 1B, C and 2B, D were
rescued of the deleterious phenotypes seen in Eng-null embryos
or in Type 3 chimeric embryos with a high contribution of donor
cells (Fig. 1D).
Earlier studies implicated Endoglin in modulating TGFβ signaling
in the yolk sac vasculature as a primary defect in Eng-null mice
(Carvalho et al., 2007; Carvalho et al., 2004). Furthermore, loss or
gain of function of the TGFβ type II receptor (TβRII) signaling in the
yolk sac in vivo demonstrated that the level of TGFβ signaling in
the extra-embryonic mesoderm is critical for development of the
blood islands, both for proper morphogenesis of the primary
vascular plexus and for differentiation of the primitive hematopoi-
etic system (Goumans et al., 1999). In rescued chimeric embryos
we did not see a difference in the contribution of Eng-null cells vs.
control heterozygous cells, nor did we observe the characteristic
block in remodeling of the vessels in the presence of a large
proportion of Eng−/− cells (Figs. 2C, D).
Endoglin is not required for EC differentiation in vitro
To further explore the role of Endoglin in angiogenic sprout
formation independent of the requirement for intact circulation, we
compared the ability of Eng-deﬁcient ES cells to form EC sprouts after
differentiation into embryoid bodies (EBs). We cultured Eng−/− and
control (Eng+/− and Eng+/+) ES cell lines in the absence of LIF, using
the hanging drop method to form EBs containing mesodermal
progenitors. As shown in Figs. 3A–C, mutant and control PECAM-1
stained ECs derived from embryoid bodies, formed sheet-like
vascular structures as well as interconnected angiogenic sprouts.
PECAM-1 stained, ﬂattened cultures were scored into one of three
categories: those displaying no angiogenic sprout formation from a
vasculogenic region and those showing fewer or greater than 10
Fig. 1. Endoglin heterozygous and mutant cells contribute to angiogenic sprouting in the chimeric embryos at E10.5. Whole mount analysis for donor cell content of ECs from
control Eng+/− (A, E, I) and Eng−/− (B–D, F–H, J–L) ES cells at E10.5 after staining with X-gal. Chimeric mice from aggregation of wild-type (WT) and Eng+/− ES cells (WT←→
Eng+/−) develop normally (A) and display donor cell contribution to angiogenic sprouting in the head (E), and intersomitic region (I). Chimeric mice from aggregation of
wild-type and Eng−/− ES cells (WT← → Eng−/−) display one of three phenotypes. Type 1 embryos contained less than 20% mutant donor cell contribution developed
normally (B), but display low donor cell contribution to vessels in the head (F) or intersomitic region (J). Type 2 embryos contained 20–50% mutant donor cell contribution
and were developmentally normal (C), and displayed mutant donor cell contribution to vessels in the head (G), intersomitic region (K). High mutant donor cell contribution
produces a deleterious knockout phenotype in Type 3 chimeras (D, H, L) with pericardial edema, growth delay and incomplete vessel remodelling in the head. Arrows
indicate donor cell contribution to the indicated tissues (scale bar: 1 mm).
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in Fig. 3D, all genotypes of ES cells produced each type of ﬂattened
culture to an equivalent extent. These ﬁndings are consistent with
the ability of Eng-null ES cells to form vascular network structures in
vivo in chimeras and support the view that Endoglin is not required
for the early steps of EC differentiation, angiogenic sprouting and
network development in the midgestation embryo.
Endoglin null cells do not contribute to endocardial cushion mesenchyme
Previous studies demonstrated that embryos lacking Endoglin
display a defect in cardiac morphogenesis, including incomplete or
absent myocardial trabeculation and AV cushion development
(Arthur et al., 2000; Bourdeau et al., 1999). This ﬁnding is con-
sistent with expression of Endoglin in endocardial cells and in the
mesenchymal derivatives that form following endocardial to
mesenchymal transition (EMT) in the atrioventricular and outﬂow
tract regions (Bourdeau et al., 1999; Jonker and Arthur, 2002; Qu
et al., 1998). Due to widespread defects in the vascular tree,
however, it was not clear to what extent cardiac morphogenesis
was affected by other circulatory defects leading to overall delay in
morphogenesis including that of the heart. Since analyses of EBs in
vitro, and chimeras in vivo suggested that angiogenesis is normalin the absence of Endoglin, we reasoned that heart morphogenesis
may be the primary impediment to development in Eng−/−
embryos.
To address this hypothesis we examined the X-gal staining
pattern of mutant and control donor cells in the endocardium and
AV cushions of chimeric embryos. As shown in Figs. 4A, C, E,
widespread Eng+/− cell contribution is observed for endocardial
cells lining the atrial and ventricular myocardium, and in the AVC
mesenchymal cell cushion. In contrast, chimeras from Eng−/− cells
displayed a range of patterns of contribution. All Type 3 embryos
in which overall donor cell contribution was high (N50%) displayed
growth retardation and abrogation of cardiac looping, as previously
described for Eng knockout embryos (Figs. 1D, L and 4B, D).
Furthermore, sections show that when high donor endocardial cell
content is evident throughout the atrium and ventricle, the endo-
cardial cushions in the AVC region are severely reduced (Fig. 4F). In
contrast, Type 1 embryos with low donor cell contribution (20%)
showed few donor cells in the endocardial compartment or cushion
mesenchyme (Figs. 4G, I), despite evidence of contribution to other
vascular structures in the embryo, albeit low (Fig. 4G, arrowheads).
Type 2 embryos, which are developmentally rescued, show that
while donor derived β-galactosidase positive cells are present in
the endocardium overlying both the AVC and OFT, almost none are
Fig. 2. Eng-null ECs display normal sprouting angiogenesis in the neural tube and yolk sac. Sections of X-gal-stained chimeric embryos demonstrate sprouting into the neural tube by
both mutant (B) and control (A) ECs (arrows), and contribution to yolk sac vasculature to a similar extent by both mutant (D) and control (C) cells. Yolk sac blood islands composed
almost entirely of Eng−/− cells show normal diameter, and cellular organization of endothelium, endoderm and mesothelial cells (scale bar: 100 μm).
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type endocardial cells could efﬁciently migrate, invade and tran-
sition to the mesenchymal lineage in this cellular context.
Therefore, the exclusion of Eng−/− cells from this structure in all
E10.5 chimeric embryos that were visibly rescued of the deleteri-
ous features of the null phenotype suggests a stringent require-
ment for Endoglin speciﬁcally in the formation of the AV cushion
mesenchyme. The presence of donor derived Eng−/− endocardial
cells, yet virtual absence from the cardiac cushion mesenchymeFig. 3. Eng-deﬁcient ECs form vascular networks in vitro. (A) Eng+/+, (B) Eng+/−, and (C)
network formation (arrows) from vasculogenic regions (⁎) to similar extent in vitro. (D)
vasculogenic region; fewer than 10 angiogenic sprouts forming from vasculogenic region; gsuggests a delay in initiation of the EMT process, or in migration of
transformed endocardial cells. Taken together with the donor–host
contribution ratios, these observations suggest that if there are only
a small number of Eng−/− donor cells contributing to the heart,
wild-type host cells can overtake the deﬁcient mutant cells, leading
to proper formation of the endocardial cushions. However, in a
Type 3 chimera where mutant donor cells exceed a critical number
in the endocardium, the endocardial cushions fail to expand
properly (Figs. 4K–N).Eng−/− embryoid bodies (EBs) stained with PECAM-1 display angiogenic sprouts and
EBs were enumerated according to the criteria: no angiogenic sprout formation from
reater than 10 angiogenic sprouts forming from vasculogenic region.
Fig. 4. Eng-null cells do not contribute to endocardial cushions. (A) Developmentally normal chimericWT←→ Eng+/− embryo at E10.5 and (C) looping heart. (B, D) Type 3WT←→
Eng−/− embryo with growth restriction, abnormal cardiac looping and pericardial edema. White lines in (A, B) indicate cutting angle for sections shown in (E, F). (E) Transverse
section ofWT←→ Eng+/− embryo AVC shows donor cell contribution to endocardial cushion mesenchyme (black arrow). (F) Hypoplastic endocardial cushions (red arrow) in Type
3WT←→ Eng−/− embryo. Red arrowheads show reduced trabeculation in Type 3 chimera compared to control (E, red arrowheads). (G, H) Sagittal sections of hearts from rescued
Type 1 and Type 2 WT←→ Eng−/− chimeric embryos with normal endocardial cushion formation. Mutant donor cells are present in endocardium and capillary ECs (arrowheads)
but not in AVC or outﬂow tract cushionmesenchyme. (I, J) high power view of AVC from embryos in G, H (box region), demonstrating predominantly host wild-type cell contribution
to mesenchyme in Type1 and Type2 chimeras (red arrows), with donor cells in endocardium (black arrows). All embryos stained with X-gal. (K–N) Interpretation of endocardial
cushion formation in chimeric embryos. (K) A subset of endocardial cells (e) in AVC populates the cardiac jelly (cj) to form cushion mesenchyme. (L) In WT←→ Eng+/− chimeras,
both donor and host cells can contribute to endocardial cushion. (M) In WT←→ Eng−/− chimeras with low donor contribution, Type2, only WT host cells populate the endocardial
cushion, whereas (N) in WT←→ Eng−/− chimeras with high donor contribution, Type3, EMT is blocked since WT cells are not sufﬁciently available. Darker blue signiﬁes Endoglin-
null cells and star shaped cells are mesenchymal cells after EMT (scale bar: A–D 1mm; E, F 200 μm; G, H 400 μm; I, J 100 μm ). lv: left ventricle; la: left atrium; v: ventricle; a: atrium;
da: dorsal aorta, fg: foregut; ec: endocardial cushion; o: outﬂow tract; ma: mandible; e: endocardium; m: myocardium; cj: cardiac jelly.
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Eng-deﬁcient embryos
To further address the requirement for Endoglin in EMT, we
compared the ability of Eng-deﬁcient vs. control embryo AVC
tissues to undergo EMT ex vivo. AVC tissue was dissected from
embryos derived from Eng+/− intercrosses and cultured onhydrated collagen I gels. We scored the ability of endocardial cells
from Eng+/+, Eng+/− and Eng−/− embryos to migrate into the gel
and undergo mesenchymal transition by phase contrast microscopy
at 24 and 48 h following plating (Figs. 5A–F), and enumerated
according to whether more or less than 50 cells had migrated at
each time point. As shown in Fig 5G, after 24 h approximately 50%
of Eng+/+ explants showed that greater than 50 mesenchymal cells
Fig. 5. Endothelial to mesenchymal transition is delayed in Eng-null embryos. Mesenchymal transformation and migration in AVC explants from Eng+/+ (A, D), Eng+/− (B, E) and
Eng−/− (C, F) at 24 h (A–C) and 48 h (D–F) after plating onto hydrated collagen I gel. Invaded cells were counted using phase microscopy for cells below the explant. (G)
Individual explants were scored according to whether greater or less than 50 cells were found migrated into the gel at 24 and 48 h. (H) Quantitative RT-PCR for endocardium
(VE-Cadherin, Nfatc1) and endocardial cushion (Sox9, Snai1, Snai2) transcripts, and VEGF, normalized to β-actin expression, using RNA from dissected hearts of stage and size
matched embryos at E9.5. Error bars represent the standard error of the mean of each sample. Data are representative of assays performed in triplicate, each using at least four
litters of embryos. ⁎ Indicates statistical signiﬁcance Pb0.05; VEGF P =0.002, Snai1 P =0.003).
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showed extensive migration. After 48 h, mesenchymal cells from
Eng−/− explants were observed in the gel, albeit fewer cultures
showed greater than 50 transformed cells when compared to
control Eng+/+ and Eng+/− (Fig. 5G). The difference in invading
cell number between Eng mutant and control explants was more
apparent at 24 h, suggesting that while EMT is not completely
abrogated in vitro in Eng−/− explants, either initiation of migration
or onset of transformation is delayed, consistent with ﬁndings using
chick explant cultures (Mercado-Pimentel et al., 2007). In addition,
we observed that while Eng+/+ and Eng+/− explants did not attach
to the collagen I matrix in approximately 6% and 8% of cultures,
respectively, Eng−/− explants did not attach in almost 30% of cases
(data not shown). This observation suggests that Eng-deﬁcient
endocardium may be compromised in its ability to interact with
extracellular matrix components of the cardiac jelly. Furthermore,
Eng-null cells that had invaded the collagen gel by 48 h displayed
a rounded morphology in contrast to the elongated cell shape of
Eng+/+ and Eng+/− explant derived invading cells. Taken together
with the ﬁnding that Eng-null cells do not contribute efﬁciently to
endocardial cushions in chimeric embryos, these data indicate that
Eng-null endocardial cells have a reduced ability to respond to
myocardial cues for invasion of the cardiac jelly, and transformation
to cushion tissue.
To further examine the defect in EMT in Eng-deﬁcient hearts we
performed quantitative real-time PCR analysis of Eng-null heart tissue
(Fig. 5H). Eng-null hearts showed signiﬁcantly diminished expression
of Snai1 (P=0.003), a transcription factor required for EMT
downstream of TGFβ family signaling (Niessen et al., 2008). In
contrast, Snai2, involved in EMT, and Nfatc1 required for cushion
development (Chang et al., 2004) were not signiﬁcantly affected in
Eng-null embryo heart. The expression of VE-Cadherin (Fig. 5H)
which modulates endothelial cell–cell contact (Taddei et al., 2008),
and is repressed by Snai1 and Snai2 (Niessen et al., 2008) was not
different between Eng-null and control embryos, suggesting that
expression of Snai2 modulates normal levels of VE-cadherin in Eng-
null embryos despite the reduced expression of Snai1. VEGF
expression was found to be signiﬁcantly upregulated in Eng-null
hearts, relative to control littermates. Previous genetic and explant
studies have demonstrated that VEGF is a potent negative regulator of
EMT (Dor et al., 2001) and is signiﬁcantly upregulated in embryos
exposed to hypoxia (Ream et al., 2008).
Abnormal patterning of the AVC in Eng-null embryos at E9.5
In addition to providing a signal for EMT, the myocardium of the
AV region is phenotypically and functionally distinct from chamber
myocardium (Christoffels et al., 2000). Disruption of the boundary
between the ventricle and atrium leads to defects in cushion
formation and embryonic lethality (Harrelson et al., 2004; Kokubo
et al., 2007). Comparison of E9.5 Eng−/− and Eng+/+ embryos,
matched for somite number, revealed a narrower constriction in
the AVC region as well as size variations of both atrial and
ventricular chambers in mutants, prompting us to examine gene
expression in this region in more detail. BMP2, which is expressedFig. 6. Abnormal AV constriction morphology and gene expression in Eng−/− embryos
at E9.5. Whole mount in situ hybridizations for the indicated genes in Eng+/+ (A, C,
E, G) and Eng−/− (B, D, F, H) hearts. Note that BMP2 expression is reduced (A, B), and
Tbx2 expression is absent in mutants (C, D), and chamber-speciﬁc gene expression of
Nppa (atrium and ventricle) and Hesr2 (ventricle) domains expand into AVC (E, F
and G, H, respectively). Brackets indicate gene expression domains and arrowheads
show the border of gene expression between ventricle and AVC. (I, J) Tunel and
phosphohistone H3 (PHH3) immunoﬂuorescence staining of Eng+/+ (I) and Eng−/−
(J) embryos. Arrows show the endocardial layer in AVC. (K, L) Alcian Blue staining for
acidic glycosaminoglycans demonstrates the presence of cardiac jelly in Eng−/− and
control embryos (scale bar: H, L 200μm).
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of endocardial cushions in the mouse (Ma et al., 2005; Rivera-
Feliciano and Tabin, 2006; Sugi et al., 2004), appeared at a reduced
level in Eng−/− embryos, but was still restricted to the inter-
chamber region (n=6) (Figs. 6A, B). In addition, expression of
Tbx2, a downstream target of BMP2 and transcriptional repressor of
chamber-speciﬁc genes in the AVC, was absent in Eng−/− embryos
(n=3) (Fig. 6D). Consistent with Tbx2 downregulation, the
domains of expression of the chamber myocardial speciﬁc genes
Nppa (Anf) (n=3) and Hesr2 (n=3) were expanded into the
AVC region in Eng knockout embryos (Figs. 6F, H) (Harrelson et al.,
2004; Kokubo et al., 2007). These results indicate that although
early speciﬁcation of the AVC myocardium occurs in the absence of
Endoglin, further expansion is not sustained, and/or patterning is
aberrant. As a result, chamber-speciﬁc markers are expressed
inappropriately, blocking subsequent morphogenesis of the AVC
region. Importantly we did not observe differences in cell proli-
feration or apoptosis in the endocardium between mutant and
control embryos (Figs. 6I, J).
Since extracellular matrix deposition within the AVC is required
for cushion formation, we examined the extent of cardiac jelly
deposition in Eng−/− vs. control hearts by staining acidic glycosa-
minoglycans with Alcian Blue. As shown in Figs. 6K, L, the cardiac
jelly appeared as extensive in mutant hearts as in controls,
suggesting that insufﬁcient extracellular matrix deposition in the
cushion forming region does not explain the inability of Eng-null
endocardial cells to undergo EMT.
Type 3 chimeras and Eng−/− embryos additionally displayed
less trabeculation of the ventricular myocardium (Figs. 4E, F and
6I, J), a phenotype that has been previously demonstrated to
reﬂect growth restriction and tissue hypoxia (Krishnan et al., 2008;
Ream et al., 2008). Furthermore, VEGF, a target of the hypoxia
responsive pathway mediated by HIF1α was signiﬁcantly increased
in Eng−/− hearts relative to control (Fig. 5H). To address the
hypothesis that Eng-null embryos are undergoing tissue hypoxia,
we measured the expression of several targets of the hypoxia
response by quantitative real time gene expression. Glut-1 and
Pfkfb3, genes expressed during anaerobic cellular respiration (Ream
et al., 2008), were signiﬁcantly upregulated in the bodies (Fig. 7)Fig. 7. Quantitative real time PCR of Eng-null vs. control E9.5 embryos for hypoxia
response transcripts. Relative gene expression normalized to β-actin for Bnip3, Glut-1,
Pfkfb3, and VEGF. All genes are targets of the hypoxia response and are signiﬁcantly
upregulated in Eng−/− embryos relative to control embryos (Pb0.005).and hearts (data not shown) of Eng−/− embryos at E9.5. VEGF was
also signiﬁcantly upregulated in Eng−/− bodies, consistent with
gene expression analysis in isolated heart tissue. Bnip3, a gene
previously shown to be upregulated prior to cellular apoptosis in
response to hypoxia (Ream et al., 2008) was also signiﬁcantly
upregulated in Eng−/− embryo bodies (Fig. 7) and hearts (data
not shown). However, Tunel staining of cardiac tissue indicated no
signiﬁcant increase in apoptotic cells in Eng−/− heart, suggesting
that E9.5 represents a window in which the Eng-null embryo
response to cardiac insufﬁciency is occurring, but viability is not
yet compromised.
Discussion
Previous studies demonstrated that loss of Endoglin affects
angiogenesis in both the yolk sac and embryo, as well as heart
morphogenesis during early development. The purpose of our study
was to determine whether Endoglin is required for both early
angiogenesis and cardiac development or if defects in either of these
processes are a secondary consequence of the other. Therefore, we
ﬁrst characterized vascular development in Eng-null embryoid
bodies and in chimeric embryos. The cultured EBs, when grown in
a system that bypasses the requirement for intact circulation, are
able to form vascular structures independent of the presence of
Endoglin (Fig. 3), consistent with previous ﬁndings (Perlingeiro,
2007). Similarly, even under the stringent competitive situation with
wild-type host cells that exists in Type 1 chimeras, we observed the
ability of Eng-null donor ES cells to differentiate into ECs that
contribute to all tissues and organ primordia (Figs. 1B, F, J),
indicating that Endoglin is not required for EC sprouting angiogen-
esis in the midgestation embryo. These results strongly support our
in vitro EB culture results and suggest that Eng-deﬁcient ES cells and
endothelial cells derived from them are normal with respect to their
angiogenic and remodelling potential in the early embryo. However,
our ﬁndings do not formally exclude the possibility that Endoglin is
required for vascular remodelling by non-cell autonomously affect-
ing the behaviour of perivascular support cells. In addition, our
experiments do not address the consequences of widespread and
complete loss of Endoglin function in mature vascular endothelium
during later gestation and in the adult.
Several studies have demonstrated that angiogenesis and vascular
patterning are dependent on normal cardiac function and the timely
establishment of hemodynamic forces in both mammalian and avian
embryos (Lucitti et al., 2007; May et al., 2004; Wakimoto et al., 2000).
Previous studies suggested that Eng mutant embryos display cardiac
looping defects and abrogation of endocardial cushion formation
(Arthur et al., 2000; Bourdeau et al., 1999).We thus hypothesized that
angiogenesis defects in Eng-null embryos could be explained by
insufﬁcient cardiac output, as a consequence of perturbed heart
morphogenesis. Therefore, in our second set of experiments, we
carefully characterized early heart development, EMT and hypoxia in
Eng-null vs. control embryos, as well as the behaviour of Eng-deﬁcient
cells in the hearts of chimeric embryos rescued of circulatory failure.
We showed that AVC and cardiac chamber restricted gene expressions
are perturbed in Eng-null embryos (Fig. 6) and that genes responsive
to hypoxia are activated signiﬁcantly in Eng-null embryos (Fig. 7). We
also showed that while Eng-deﬁcient cells contributed readily to
blood vessels, they did not contribute to the mesenchymal population
in the AV cushions in developmentally rescued Type2 chimeric
embryos (Figs. 1C, G, K, 2B, D, and 4H, J). This ﬁnding is consistent
with a delay in invasion and migration of AVC derived cells in ex vivo
cultures of Eng-null explants (Figs. 5A–G).
Taken together, our data indicate that the absence of Endoglin
leads to a disruption in the patterning of the AVC, causing inappro-
priate boundary formation between the cardiac chambers leading to a
delay in the onset of cardiac function, or its insufﬁciency. This in turn
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decreased oxygen perfusion, hypoxia and growth delay.When cardiac
insufﬁciency is bypassed, as in Type 2 chimeras where growth delay,
cardiac looping defects, endocardial cushion formation and angio-
genesis defects are rescued (Figs. 1C, G, K, 2B, D, and 4H, J), Eng−/−
endocardial cells were at a competitive disadvantage in the process of
cushion formation, since these tissues were found to be composed
almost exclusively of wild-type donor tissue (Figs. 4H, J). Therefore,
our data suggest that in the early embryo, Endoglin is ﬁrst required for
patterning the AVC and is subsequently required in endocardial cells
for EMT. Furthermore, in the Eng-null heart, high VEGF production,
likely as a consequence of hypoxia in the cardiac chambers (Fig. 5H),
may also contribute to the suppression of EMT (Dor et al., 2001),
compounding the effects of incorrect cellular patterning in the AVC.
Endoglin's role as a component of the TGFβ1 signaling complex
has been extensively characterized in endothelial cells in vitro
(Lastres et al., 1996; Lebrin et al., 2004; Pece-Barbara et al., 2005),
and a role for TGFβ1/β3 ligands during EMT in the developing heart
was suggested from avian studies using the collagen explant system
(Potts and Runyan, 1989; Proetzel et al., 1995). However, in vivo
mouse genetic analyses do not support a central role for TGFβ1/β3
signalling during EMT, although this pathway is likely required for
later steps of valve maturation (Bartram et al., 2001; Dickson et al.,
1995; Dunker and Krieglstein, 2002; Kaartinen et al., 1995; Proetzel
et al., 1995; Sanford et al., 1997; Sridurongrit et al., 2008). In
particular, endothelial and myocardial speciﬁc knockouts of TβRII
(Jiao et al., 2006; Park et al., 2008), the only Type II receptor
available for TGFβ1/β3 signaling, strongly indicate that these growth
factors are largely dispensable for early cardiac morphogenesis and
in particular for formation of the AV cushion mesenchyme. This
argues that some compensatory stimulus induces EMT in the
absence of TGFβ signaling and that Endoglin likely interacts with
this pathway to modulate EMT.
In this regard, Endoglin can interact with multiple TGFβ super-
family members in addition to TGFβ1 and TGFβ3, including ActivinA,
BMP2, BMP7 and BMP9 in the presence of the appropriate ligand
binding receptor (Barbara et al., 1999; David et al., 2007). Both
BMP2 and BMP7 have been implicated in AV cushion development.
Endoglin may mediate the effects of BMP2 speciﬁcally in the AVC
endocardium due to BMP2 restricted expression in the AVC
myocardium (Fig. 6A) (Lyons et al., 1995). Moreover, BMP2 can
potently induce EMT in mouse cardiac explants (Sugi et al., 2004).
Conditional mutagenesis of BMP2 and its downstream signalling
receptors, Bmpr2, and Alk3(Bmpr1a) interfere with early cushion
formation (Gaussin et al., 2002; Ma et al., 2005; Park et al., 2006;
Rivera-Feliciano and Tabin, 2006; Song et al., 2007). The defects
described for BMP2 deletion in cardiac tissue (Ma et al., 2005;
Rivera-Feliciano and Tabin, 2006), are consistent with our ﬁndings in
Eng−/− embryos. In both cases, EMT does not occur, and AVC
myocardium expresses genes characteristic of differentiated cham-
ber myocardium, consistent with the view that Endoglin modulates
BMP2 signaling in the heart. On the other hand, BMP2-deﬁcient
hearts displayed a defect in cardiac jelly deposition (Ma et al., 2005;
Rivera-Feliciano and Tabin, 2006), whereas this was not observed in
Eng−/− embryos, suggesting that endocardial cushion swelling
mediated by BMP2 does not involve Endoglin. We showed that
BMP2 expression in the AVC myocardium was reduced in Eng-null
embryos and that EMT is delayed in these embryos in vitro. In Type
2 rescued chimeras, where cushion formation is restored (Figs. 4H, J),
Eng-null cells cannot respond to EMT induction signals to the same
extent as wild-type cells. This indicates that, while reduced BMP2
expression contributes to the block in EMT in Eng−/− embryos,
Endoglin is subsequently also required cell autonomously in
endocardium to respond to the EMT induction cues, because chimera
analysis showed that only wild-type, Endoglin expressing donor
cells populate the endocardial cushions in embryos rescued ofdefects. Thus, it is interesting to consider that Endoglin may modu-
late several responses required in the AVC endocardium: ﬁrst for
patterning the AVC myocardium leading to the induction of BMP2
and its downstream modulators, and secondly for induction of
cellular events leading to EMT. In this regard, BMP7, another ligand
for Endoglin is also expressed throughout the mouse heart tube from
E8.5 (Lyons et al., 1995), and may play a role in these processes.
Further experiments to determine Endoglin's functional role in BMP
2, 7, and 9 signalling, in the endocardium are required to pinpoint
the molecular mechanism of its role in heart development.
Our study shows that Endoglin expression and function in endo-
cardial cells is required for proper patterning of the myocardium at
E9.5. This indicates that signals leading to induction of BMP2 and Tbx2
in the AVC myocardium are derived from the endocardium. The
importance of endocardial–myocardial signalling has been documen-
ted in EMT and trabeculation of the ventricles (Wagner and Siddiqui,
2007). Our results suggest that endocardial-myocardial signalling is
also requisite for the process of patterning the atrioventricular
boundary. Live-cell imaging studies in zebraﬁsh demonstrated the
requirement for the earliest speciﬁed endocardial cells to direct the
movement of cardiomyocytes in formation of a functioning heart tube
(Holtzman et al., 2007). Since Endoglin is expressed in endocardial
cells from their ﬁrst appearance in the cardiac crescent (Arthur et al.,
2000), it will be important to deﬁne the mechanisms by which
Endoglin patterns the AVC myocardium, and how it directs the
transcriptional networks that are essential for cardiac morphogenesis.
Recently, endothelial-to-mesenchymal transition, a process analo-
gous to embryonic EMT has been implicated in cardiac ﬁbrosis,
leading to cardiac hypertrophy, a condition associated with myocar-
dial dysfunction and morbidity. In this regard, TGFβ1 and BMP7, both
Endoglin ligands, were found to be mutually antagonistic in this
process (Zeisberg et al., 2007). It will be interesting to determine
whether Endoglin is also involved in EMT leading to cardiac ﬁbrosis,
and whether it plays a role in this disease.
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